These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17717205)

  • 1. Role of alpha1-acid glycoprotein in therapeutic antifibrotic effects of imatinib with macrolides in mice.
    Azuma M; Nishioka Y; Aono Y; Inayama M; Makino H; Kishi J; Shono M; Kinoshita K; Uehara H; Ogushi F; Izumi K; Sone S
    Am J Respir Crit Care Med; 2007 Dec; 176(12):1243-50. PubMed ID: 17717205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice.
    Aono Y; Nishioka Y; Inayama M; Ugai M; Kishi J; Uehara H; Izumi K; Sone S
    Am J Respir Crit Care Med; 2005 Jun; 171(11):1279-85. PubMed ID: 15735062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.
    Distler JH; Jüngel A; Huber LC; Schulze-Horsel U; Zwerina J; Gay RE; Michel BA; Hauser T; Schett G; Gay S; Distler O
    Arthritis Rheum; 2007 Jan; 56(1):311-22. PubMed ID: 17195235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nilotinib on bleomycin-induced acute lung injury and pulmonary fibrosis in mice.
    Rhee CK; Lee SH; Yoon HK; Kim SC; Lee SY; Kwon SS; Kim YK; Kim KH; Kim TJ; Kim JW
    Respiration; 2011; 82(3):273-87. PubMed ID: 21659722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifibrotic effects of focal adhesion kinase inhibitor in bleomycin-induced pulmonary fibrosis in mice.
    Kinoshita K; Aono Y; Azuma M; Kishi J; Takezaki A; Kishi M; Makino H; Okazaki H; Uehara H; Izumi K; Sone S; Nishioka Y
    Am J Respir Cell Mol Biol; 2013 Oct; 49(4):536-43. PubMed ID: 23642017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the protein kinase inhibitor, imatinib mesylate, on epithelial/mesenchymal phenotypes: implications for treatment of fibrotic diseases.
    Vittal R; Zhang H; Han MK; Moore BB; Horowitz JC; Thannickal VJ
    J Pharmacol Exp Ther; 2007 Apr; 321(1):35-44. PubMed ID: 17218487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imatinib mesylate attenuates fibrosis in coxsackievirus b3-induced chronic myocarditis.
    Leipner C; Grün K; Müller A; Buchdunger E; Borsi L; Kosmehl H; Berndt A; Janik T; Uecker A; Kiehntopf M; Böhmer FD
    Cardiovasc Res; 2008 Jul; 79(1):118-26. PubMed ID: 18326555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis.
    Chaudhary NI; Roth GJ; Hilberg F; Müller-Quernheim J; Prasse A; Zissel G; Schnapp A; Park JE
    Eur Respir J; 2007 May; 29(5):976-85. PubMed ID: 17301095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis.
    Akhmetshina A; Venalis P; Dees C; Busch N; Zwerina J; Schett G; Distler O; Distler JH
    Arthritis Rheum; 2009 Jan; 60(1):219-24. PubMed ID: 19116940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model.
    Chaudhary NI; Schnapp A; Park JE
    Am J Respir Crit Care Med; 2006 Apr; 173(7):769-76. PubMed ID: 16415276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum α1-acid glycoprotein, imatinib concentration and efficacy in chronic myeloid leukemia patients].
    Zhong JS; Meng FY; Xu D; Dai M; Wei YQ; Zhou HS
    Zhonghua Yi Xue Za Zhi; 2011 Aug; 91(30):2120-3. PubMed ID: 22093988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.
    Oku H; Shimizu T; Kawabata T; Nagira M; Hikita I; Ueyama A; Matsushima S; Torii M; Arimura A
    Eur J Pharmacol; 2008 Aug; 590(1-3):400-8. PubMed ID: 18598692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effects of evasin-1, a chemokine binding protein, in bleomycin-induced pulmonary fibrosis.
    Russo RC; Alessandri AL; Garcia CC; Cordeiro BF; Pinho V; Cassali GD; Proudfoot AE; Teixeira MM
    Am J Respir Cell Mol Biol; 2011 Jul; 45(1):72-80. PubMed ID: 20833968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of imatinib mesylate on bleomycin-induced pulmonary fibrosis in mice].
    Li L; Li YQ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Apr; 19(4):229-32. PubMed ID: 17448279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imatinib mesylate inhibits fibrogenesis in asbestos-induced interstitial pneumonia.
    Vuorinen K; Gao F; Oury TD; Kinnula VL; Myllärniemi M
    Exp Lung Res; 2007 Sep; 33(7):357-73. PubMed ID: 17849262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imatinib mesylate inhibits proliferation and exerts an antifibrotic effect in human breast stroma fibroblasts.
    Gioni V; Karampinas T; Voutsinas G; Roussidis AE; Papadopoulos S; Karamanos NK; Kletsas D
    Mol Cancer Res; 2008 May; 6(5):706-14. PubMed ID: 18505916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated alpha1-acid glycoprotein in gastric cancer patients inhibits the anticancer effects of paclitaxel, effects restored by co-administration of erythromycin.
    Ohbatake Y; Fushida S; Tsukada T; Kinoshita J; Oyama K; Hayashi H; Miyashita T; Tajima H; Takamura H; Ninomiya I; Yashiro M; Hirakawa K; Ohta T
    Clin Exp Med; 2016 Nov; 16(4):585-592. PubMed ID: 26359244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of bleomycin-induced pulmonary fibrosis by a novel antifibrotic peptide with relaxin-like activity.
    Pini A; Shemesh R; Samuel CS; Bathgate RA; Zauberman A; Hermesh C; Wool A; Bani D; Rotman G
    J Pharmacol Exp Ther; 2010 Dec; 335(3):589-99. PubMed ID: 20826567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel inhibitor of Smad-dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis.
    Hasegawa M; Matsushita Y; Horikawa M; Higashi K; Tomigahara Y; Kaneko H; Shirasaki F; Fujimoto M; Takehara K; Sato S
    Arthritis Rheum; 2009 Nov; 60(11):3465-75. PubMed ID: 19877032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha1 acid glycoprotein binds to imatinib (STI571) and substantially alters its pharmacokinetics in chronic myeloid leukemia patients.
    Gambacorti-Passerini C; Zucchetti M; Russo D; Frapolli R; Verga M; Bungaro S; Tornaghi L; Rossi F; Pioltelli P; Pogliani E; Alberti D; Corneo G; D'Incalci M
    Clin Cancer Res; 2003 Feb; 9(2):625-32. PubMed ID: 12576428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.